博瑞医药: 关于“博瑞转债”跟踪信用评级结果的公告

Core Viewpoint - The company maintains its credit rating of "AA-" with a stable outlook for both its corporate entity and the "Bory Pharmaceutical Convertible Bonds" [1][2] Group 1: Credit Rating Information - The previous credit rating for the company was "AA-" with a stable outlook, and the same rating applies to the "Bory Convertible Bonds" [1] - The recent credit rating report from Dongfang Jincheng International Credit Assessment Co., Ltd. confirms the maintenance of the company's credit rating at "AA-" and the stable outlook [2] - The credit rating report is available on the Shanghai Stock Exchange website, detailing the company's and bonds' ratings for the year 2025 [2]